Eczema Trial, Recruiting NCT06732414 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT06732414
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 3 to 100 years old
  • People who have a suspected or confirmed allergy, atopic condition (such as eczema), breathing disorder, or nasal/sinus condition, OR a history of an immune system disorder
  • People who have had a past reaction — such as hives, swelling, or anaphylaxis — to things like pollen, food, insect stings, or medications
  • People who are able to give their consent to take part in the study
  • People who have, or are willing to find, a regular doctor outside of this research centre who can manage their general health and respond in a medical emergency if needed
  • People who are willing to allow samples such as blood, skin swabs, nasal fluid, and other tissue to be stored for future medical research

Who may not be able to join:

  • People with any physical or psychological condition that the study doctor believes would make participation unsuitable
  • People under 18 years old, people who are pregnant, or people with a history of raised/thickened scar formation — for the optional skin biopsy procedure only
  • People under 18 years old, or people who are pregnant — for the optional nasal/sinus polyp biopsy procedure only (people on blood thinners may also be excluded unless those medications have been safely stopped before the procedure)
  • People who are pregnant — for the skin prick testing procedure only
  • For the optional gut/airway (endoscopic) biopsy procedure only, people who: have poorly controlled asthma or a serious physical health classification (confirm with trial site); have previously had a bad reaction to sedation or general anaesthetic; have low haemoglobin (a measure of red blood cells) or low platelet counts (cells that help blood clot); are pregnant or breastfeeding; have severe low oxygen levels due to a chronic lung condition; have had recent abdominal surgery; are on blood thinners that cannot be paused; or are under 18 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paneez Khoury, M.D., National Institute of Allergy and Infectious Diseases (NIAID)

Phone: (301) 594-1233

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 January 2025
Est. completion
1 November 2044

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Create a repository of clinical, laboratory, and diagnostic data and specimens from a cohort of suspected or confirmed atopic or allergic individuals with diverse disorders seen by allergist-immunologists and rhinologists.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov